Skip to Content

PLIVA 787 (Azithromycin Monohydrate 250 mg)

Pill with imprint PLIVA 787 is White, Elliptical / Oval and has been identified as Azithromycin Monohydrate 250 mg. It is supplied by Pliva Inc..

Azithromycin is used in the treatment of bacterial infection; bacterial endocarditis prevention; babesiosis; bartonellosis; typhoid fever and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Azithromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLIVA 787

Azithromycin monohydrate 250 mg PLIVA 787
Azithromycin monohydrate 250 mg PLIVA 787 Front
Azithromycin monohydrate 250 mg PLIVA 787 Back
Azithromycin monohydrate 250 mg PLIVA 787

Azithromycin Monohydrate

Imprint
PLIVA 787
Strength
250 mg
Color
White
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Macrolides
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pliva Inc.
Inactive Ingredients
corn starch, calcium phosphate dibasic anhydrous, croscarmellose sodium, hypromellose 2910 (15 mPa.s), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 4000, trisodium citrate dihydrate, sodium lauryl sulfate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
50111-0787 Pliva
43063-0090 PDRX Pharmaceuticals Inc. (repackager)
53002-2224 Pharmedix (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.